help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-1068
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
149/5/2051    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeMambro, V. E.
Right arrow Articles by Rosen, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeMambro, V. E.
Right arrow Articles by Rosen, C. J.
Endocrinology Vol. 149, No. 5 2051-2061
Copyright © 2008 by The Endocrine Society

Gender-Specific Changes in Bone Turnover and Skeletal Architecture in Igfbp-2-Null Mice

V. E. DeMambro, D. R. Clemmons, L. G. Horton, M. L. Bouxsein, T. L. Wood, W. G. Beamer, E. Canalis and C. J. Rosen

The Jackson Laboratory (V.E.D., L.G.H., W.G.B., C.J.R.), Bar Harbor, Maine 04609; University of North Carolina (D.R.C.), Chapel Hill, North Carolina 27514; Beth Israel Deaconess Medical Center (M.L.B.), Boston, Massachusetts 02215; University of New Jersey School of Medicine (T.L.W.), Newark, New Jersey 07103; and St. Francis Hospital (E.C.), Hartford, Connecticut 06105

Address all correspondence and requests for reprints to: Clifford J. Rosen, M.D., The Jackson Laboratory, 600 Main Street, Bar Harbor, Maine 04609. E-mail: rofe{at}aol.com.

IGF-binding protein-2 (IGFBP-2) is a 36-kDa protein that binds to the IGFs with high affinity. To determine its role in bone turnover, we compared Igfbp2–/– mice with Igfbp2+/+ colony controls. Igfbp2–/– males had shorter femurs and were heavier than controls but were not insulin resistant. Serum IGF-I levels in Igfbp2–/– mice were 10% higher than Igfbp2+/+ controls at 8 wk of age; in males, this was accompanied by a 3-fold increase in hepatic Igfbp3 and Igfbp5 mRNA transcripts compared with Igfbp2+/+ controls. The skeletal phenotype of the Igfbp2–/– mice was gender and compartment specific; Igfbp2–/– females had increased cortical thickness with a greater periosteal circumference compared with controls, whereas male Igfbp2–/– males had reduced cortical bone area and a 20% reduction in the trabecular bone volume fraction due to thinner trabeculae than Igfbp2+/+ controls. Serum osteocalcin levels were reduced by nearly 40% in Igfbp2–/– males, and in vitro, both CFU-ALP+ preosteoblasts, and tartrate-resistant acid phosphatase-positive osteoclasts were significantly less abundant than in Igfbp2+/+ male mice. Histomorphometry confirmed fewer osteoblasts and osteoclasts per bone perimeter and reduced bone formation in the Igfbp2–/– males. Lysates from both osteoblasts and osteoclasts in the Igfbp2–/– males had phosphatase and tensin homolog (PTEN) levels that were significantly higher than Igfbp2+/+ controls and were suppressed by addition of exogenous IGFBP-2. In summary, there are gender- and compartment-specific changes in Igfbp2–/– mice. IGFBP-2 may regulate bone turnover in both an IGF-I-dependent and -independent manner.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society